Categories Earnings, Health Care

Sarepta Therapeutics (SRPT): Q4 2019 Earnings Snapshot

Earnings Update by AlphaStreet

—  Sarepta Therapeutics, Inc.  (NASDAQ: SRPT) reported a loss of $1.57 per share in the fourth quarter of 2019, vs $1.86 per share loss expected.

— Q4 revenue rose 19% to $100.1 million, vs. $98.8 million expected. Results were helped by an increase in demand for EXONDYS 51 in the U.S.

— Appointed biotech executive John C. Martin to Board of Directors. He is a former Gilead CEO.

— SRPT shares ended Wednesday’s regular trading session down 1.14%. 

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Also Read:  Infographic: Highlights of Autodesk's (ADSK) Q3 2021 earnings

Most Popular

Earnings reports to watch for the week of Nov. 30

The recent optimism about economic recovery waned slightly this week after jobless claims increased more-than-expected to about 778,000 amid concerns over a resurgence in coronavirus cases. With the healthcare system

Yunji Inc. (YJ) Q3 2020 Earnings Call Transcript

Yunji Inc. (NASDAQ: YJ) Q3 2020 earnings call dated Nov. 26, 2020 Corporate Participants: Kaye Liu -- Investor Relations Director Shanglue Xiao -- Chairman of the Board of Directors and Chief Executive Officer Chen

Huge AWS outage affects a wide range of applications

Amazon Web Services (AWS), a leading cloud computing platform, went down in the morning hours of Wednesday. Many applications – including Anchor, Adobe Spark, Flickr, SiriusXM and Roku reported disruption

Top